DC
AMPH icon

Deere & Company’s Amphastar Pharmaceuticals AMPH Stock Holding History

Deere & Company’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,260
Closed -$384K – 55
2016
Q3 		$384K Hold
20,260
– – 0.02% 769
2016
Q2 		$327K Buy
+20,260
New +$286K 0.02% 821

Other funds holding AMPH

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deere & Company's AMPH Position: Q4 2016 in Review

Deere & Company sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2016, closing a stake of 20,260 shares — an estimated $384K sold.

Deere & Company first reported a position in AMPH in Q2 2016 and held it in 2 quarters. The position peaked at $384K in Q3 2016. 138 funds tracked by Wall St. Rank hold AMPH as of Q4 2016.

  • Deere & Company reported no remaining Amphastar Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 20,260 Amphastar Pharmaceuticals shares in Q4 2016, an estimated $384K.
  • Deere & Company first reported a position in Amphastar Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Deere & Company's Amphastar Pharmaceuticals position peaked at $384K in Q3 2016.
  • 138 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.